Jasper Therapeutics, Inc. JSPRW Stock
Jasper Therapeutics, Inc. Price Chart
Jasper Therapeutics, Inc. JSPRW Financial and Trading Overview
| Jasper Therapeutics, Inc. stock price | 0.0002 USD |
| Previous Close | 0.0013 USD |
| Open | 0.08 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0039 USD |
| 52 Week Range | 0.0001 - 0.0039 USD |
| Volume | 863.07K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.836 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
JSPRW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.0039999997 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Jasper Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 0.0039 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
JSPRW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -3.836 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Jasper Therapeutics, Inc.
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 2200 Bridge Pkwy |
| ZIP | 94065 |
| Phone | 650-549-1400 |
| Website | https://jaspertx.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Q&A For Jasper Therapeutics, Inc. Stock
What is a current JSPRW stock price?
Jasper Therapeutics, Inc. JSPRW stock price today per share is 0.0002 USD.
How to purchase Jasper Therapeutics, Inc. stock?
You can buy JSPRW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jasper Therapeutics, Inc.?
The stock symbol or ticker of Jasper Therapeutics, Inc. is JSPRW.
How many shares does Jasper Therapeutics, Inc. have in circulation?
The max supply of Jasper Therapeutics, Inc. shares is 0.
What is Jasper Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Jasper Therapeutics, Inc. PE Ratio is now.
What was Jasper Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Jasper Therapeutics, Inc. EPS is -3.836 USD over the trailing 12 months.
